1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "18323-44-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-B1455
    Clindamycin

    Bacterial Infection
    Clindamycin is an oral protein synthesis inhibitory agent that has the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla).